PHARMACEUTICAL AGENT FOR TREATMENT OF SKIN DISEASES WITH PRIMARY AND SECONDARY INFECTION Russian patent published in 2008 - IPC A61K31/616 A61K31/375 A61K31/496 A61K31/4174 A61K9/00 A61P17/02 

FIELD: medicine; pharmacology.

SUBSTANCE: agent for treatment of infectious and immune skin diseases with secondary infection, is produced as a pharmaceutical agent for external application and contains antimycotics and ascorbic acid in the following proportion of active ingredients per 100 g base: 2.5 g ascorbic acid to 50 g antimycotics from imidazole group including myconazole 0.3 g. econazole 1 g, ketoconazole 2 g, allyl amino derivatives - terbinafine 1 g, naftifine 1 g, polyene antibiotics - amfotericin B 3000000, nystatin 10000000 U, natamycine, levorine 50000000 U, nitrogen compounds - clotrimazole 1 g, isoconazole 1 g, bifonazole 1 g, sertaconazole 2 g, morpholine derivatives - amorolfine 2.5 g, tolnaftate, cyclo pyrocholamine, anmarinum 1 g; base up to 100 g. In addition, the medicine contains glucocorticosteroids 0.005-1 g, salicylic acid 1-1.5 g, antibiotics from aminoglycosides, such as neomycin 25000 IU 2 g, gentamycin 0.1 g, polypentide.

antibiotic - zinc bacitracyne 500000 IU, tetracyclines 3 g, tetracycline 0,71 g and oleandomycine 0,43 g, macrolides - erythromycin 1000000 IU 4 g, lincosamides - clindamycin 0,1 g, rifampicins - rifampicin 1 g, antibiotics of different groups - lincomicin 1-5 g, synthomycin 1-5 g, heliomycin 4,0 g, gramicidin 2,0 g, sodium fuzidat, polymixin 2000000 IU, garamycin 0,1-0,25 g, and the medicine can be prepared as solution, hydrogel, cream, ointment and paste.

EFFECT: agent increases efficiency of dermatologic medicines and at the same time, prevents complications

5 cl, 19 ex, 2 tbl